Researchers
-
Asunción Ávila
Vascular risk
Phd -
Luis Miguel Ceresuela
Vascular risk
-
Manuel Jesús Gómez-choco
Vascular risk
Phd -
Montserrat Martín-baranera
Vascular risk
Phd
-
Pedro Armario
Vascular risk
Phd -
Peter Blanch
Vascular risk
Phd -
Rachel Hernandez
Vascular risk
Phd
Contact the group
Form
Projects
-
- Year 2019
- L'Hospitalet General Hospital
Monitoring the Mobility of Parkinson's patients with therapeutic purposes - Clinical Trial.
-
DISTRICT ATTORNEY:
Consorcio Sanitari del Garraf
-
TYPE E:
P.S
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Study of Alzheimer's Disease biomarkers in the cerebrospinal fluid of patients with cognitive impairment in the Integral Health Consortium,
-
DISTRICT ATTORNEY:
Asunción Ávila
-
TYPE E:
PINE TREE
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Radiological and hemodynamic characteristics of lacunar strokes depending on their location.
-
DISTRICT ATTORNEY:
Manuel Gómez Choco
-
TYPE E:
PINE TREE
-
- Year 2019
- L'Hospitalet General Hospital
Observational, prospective, multinational, multicenter study comparing the effectiveness of Safinamide, Rasagiline and other standard treatments as complementary treatment to Levadopa (L-dopa) in patients with fluctuating Parkinson's disease (PD).
-
DISTRICT ATTORNEY:
Zambon S.p.A
-
TYPE E:
EPA-SP
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Analysis of the prognostic significance of the location and size of the infarct
in patients with ischemic stroke.-
DISTRICT ATTORNEY:
Dr. Xabier Urra Nuin from the Neurology Service of the Hospital Clínic de Barcelona
-
TYPE E:
PINE TREE
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
International phase 2, randomized, double-blind, placebo-controlled, dose-response-matched study of BMS-986177, an oral factor XIa inhibitor, for the prevention of a new case of ischemic stroke or re-silent cerebral infarction in patients treated with aspirin and clopidogrel after an acute ischemic stroke or a transient ischemic attack (TIA).
-
DISTRICT ATTORNEY:
Bristol-Myers Squibb Research and Development
-
TYPE E:
RD2015
-
Vascular risk
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Healthy lifestyle modification and treatment monitoring in secondary stroke prevention by means of a digital platform for mobile devices in multiple centers in Catalonia,
-
DISTRICT ATTORNEY:
Dr. Marc Ribo Neurology Service. Vall d´Hebrón University Hospital
-
TYPE E:
PI
-
Vascular risk
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
CONVINCE (Colchicine for the prevention of vascular inflammation in non-cardioembolic cerebrovascular accidents) - a randomized clinical trial of low-dose colchicine for secondary prevention after a cerebrovascular accident,
-
DISTRICT ATTORNEY:
University College Dublin
-
TYPE E:
RD2015
-
Vascular risk
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Evaluation of the variability of positional and temporal blood pressure and its relationship with organic damage in hypertensive elderly (VARIAN study),
-
DISTRICT ATTORNEY:
Dr. Patricia Fernández Llama of the Puigvert Foundation
-
TYPE E:
PI
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Healthy lifestyle modification and treatment monitoring in secondary stroke prevention by means of a digital platform for mobile devices in multiple centers in Catalonia,
-
DISTRICT ATTORNEY:
Dr. Marc Ribo Neurology Service. Vall d´Hebrón University Hospital
-
TYPE E:
PINE TREE
Lines of action
- Resistant hypertension and refractory hypertension
- Arterial stiffness in hypertension and cerebrovascular disease
- Small vessel cerebrovascular disease: Lacunar infarction
- Factors associated with stroke recurrences
- Thrombolytic treatment and acute stroke care circuits
- Prognostic value of premorbid BP and BP in the acute phase of stroke
